FGF21 MUTANTS AND USES THEREOF
The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | ELLISON, Murielle Marie LI, Yue-Sheng XU, Jing SUN, Jeonghoon BELOUSKI, Edward John HAMBURGER, Agnes Eva MICHAELS, Mark Leo HECHT, Randy Ira |
description | The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4353247A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4353247A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4353247A33</originalsourceid><addsrcrecordid>eNrjZJBzc3czMlTwDQ1x9AsJVnD0c1EIDXYNVgjxcA1y9XfjYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgEmxqbGRibmjsbGRCgBAFKKIKs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FGF21 MUTANTS AND USES THEREOF</title><source>esp@cenet</source><creator>ELLISON, Murielle Marie ; LI, Yue-Sheng ; XU, Jing ; SUN, Jeonghoon ; BELOUSKI, Edward John ; HAMBURGER, Agnes Eva ; MICHAELS, Mark Leo ; HECHT, Randy Ira</creator><creatorcontrib>ELLISON, Murielle Marie ; LI, Yue-Sheng ; XU, Jing ; SUN, Jeonghoon ; BELOUSKI, Edward John ; HAMBURGER, Agnes Eva ; MICHAELS, Mark Leo ; HECHT, Randy Ira</creatorcontrib><description>The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240717&DB=EPODOC&CC=EP&NR=4353247A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240717&DB=EPODOC&CC=EP&NR=4353247A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ELLISON, Murielle Marie</creatorcontrib><creatorcontrib>LI, Yue-Sheng</creatorcontrib><creatorcontrib>XU, Jing</creatorcontrib><creatorcontrib>SUN, Jeonghoon</creatorcontrib><creatorcontrib>BELOUSKI, Edward John</creatorcontrib><creatorcontrib>HAMBURGER, Agnes Eva</creatorcontrib><creatorcontrib>MICHAELS, Mark Leo</creatorcontrib><creatorcontrib>HECHT, Randy Ira</creatorcontrib><title>FGF21 MUTANTS AND USES THEREOF</title><description>The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJBzc3czMlTwDQ1x9AsJVnD0c1EIDXYNVgjxcA1y9XfjYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgEmxqbGRibmjsbGRCgBAFKKIKs</recordid><startdate>20240717</startdate><enddate>20240717</enddate><creator>ELLISON, Murielle Marie</creator><creator>LI, Yue-Sheng</creator><creator>XU, Jing</creator><creator>SUN, Jeonghoon</creator><creator>BELOUSKI, Edward John</creator><creator>HAMBURGER, Agnes Eva</creator><creator>MICHAELS, Mark Leo</creator><creator>HECHT, Randy Ira</creator><scope>EVB</scope></search><sort><creationdate>20240717</creationdate><title>FGF21 MUTANTS AND USES THEREOF</title><author>ELLISON, Murielle Marie ; LI, Yue-Sheng ; XU, Jing ; SUN, Jeonghoon ; BELOUSKI, Edward John ; HAMBURGER, Agnes Eva ; MICHAELS, Mark Leo ; HECHT, Randy Ira</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4353247A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ELLISON, Murielle Marie</creatorcontrib><creatorcontrib>LI, Yue-Sheng</creatorcontrib><creatorcontrib>XU, Jing</creatorcontrib><creatorcontrib>SUN, Jeonghoon</creatorcontrib><creatorcontrib>BELOUSKI, Edward John</creatorcontrib><creatorcontrib>HAMBURGER, Agnes Eva</creatorcontrib><creatorcontrib>MICHAELS, Mark Leo</creatorcontrib><creatorcontrib>HECHT, Randy Ira</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ELLISON, Murielle Marie</au><au>LI, Yue-Sheng</au><au>XU, Jing</au><au>SUN, Jeonghoon</au><au>BELOUSKI, Edward John</au><au>HAMBURGER, Agnes Eva</au><au>MICHAELS, Mark Leo</au><au>HECHT, Randy Ira</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FGF21 MUTANTS AND USES THEREOF</title><date>2024-07-17</date><risdate>2024</risdate><abstract>The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP4353247A3 |
source | esp@cenet |
subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | FGF21 MUTANTS AND USES THEREOF |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T11%3A39%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ELLISON,%20Murielle%20Marie&rft.date=2024-07-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4353247A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |